Knowledge, Attitudes, and Practices of Operative Vaginal Birth Among Obstetric Providers in Egypt

July 1, 2025 updated by: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy, Al-Azhar University

The goal of this observational study is to evaluate the knowledge, attitudes, and practices of operative vaginal birth among obstetric providers in Egypt. The main questions it aims to answer are:

  • What is the level of knowledge among obstetric providers regarding operative vaginal birth?
  • What are the attitudes and practices of obstetric providers towards operative vaginal birth?

Participants will:

  • Complete a detailed questionnaire assessing their knowledge, attitudes, and practices related to operative vaginal birth.
  • Provide demographic information to contextualize their responses.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Egypt
    • Cairo.
      • Cairo, Cairo., Egypt
        • Faculty od Medicine, Department of Obstetrics and Gynecology.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This study focuses exclusively on obstetricians and gynecologists practicing in Egypt. These healthcare professionals are actively involved in providing obstetric care and have direct experience with operative vaginal births. Participants will be recruited from various healthcare settings, including public and private hospitals, ensuring a diverse representation of clinical perspectives and experiences across different practice environments within Egypt.

Description

Inclusion Criteria:

  • Licensed Obstetricians: Only obstetricians who are currently licensed to practice in Egypt.
  • Active Practice: Obstetricians who are actively practicing in hospitals or clinics in Egypt.
  • Experience: Obstetricians with a minimum of one year of experience in obstetrics and gynecology.
  • Consent: Willingness to participate and provide informed consent.
  • Language: Ability to understand and complete the questionnaire in English.

Exclusion Criteria:

  • Non-Obstetricians: Healthcare providers who are not obstetricians.
  • Inactive Practice: Obstetricians who are not currently practicing in Egypt.
  • Insufficient Experience: Obstetricians with less than one year of experience in the field.
  • Non-Consent: Individuals who do not provide informed consent to participate in the study.
  • Language Barrier: Obstetricians who are unable to understand and complete the questionnaire in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Health Provider
The study will include obstetricians and gynecologists practicing in Egypt. These healthcare professionals specialize in the management of pregnancy, childbirth, and women's reproductive health. Participants will be recruited from various healthcare settings, including public and private hospitals, ensuring a diverse representation of clinical experiences and perspectives on operative vaginal birth practices. All participants must actively engage in obstetric care and possess direct experience with operative vaginal births, allowing for an in-depth exploration of their knowledge, attitudes, and practices related to this procedure within the Egyptian healthcare context.
Other: Designed Questionnaire
Participants in this study, comprised solely of obstetricians and gynecologists practicing in Egypt, will complete a self-administered questionnaire designed to assess their knowledge, attitudes, and practices related to operative vaginal birth. The questionnaire includes four sections: the first gathers demographic data such as name, gender, and years of experience in childbirth care; the second focuses on participants' practices regarding the frequency and types of operative vaginal birth used (forceps, ventouse) and reasons for their use; the third evaluates knowledge of outcomes associated with operative vaginal birth through multiple-choice questions; and the fourth explores attitudes towards operative vaginal birth, including opinions on hospital rates and policy appropriateness. Completion and return of the questionnaire, which takes approximately 5 to 10 minutes, will be considered as consent to participate in the study.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Knowledge of Operative Vaginal Birth Among Obstetric Providers
Time Frame: Within 6 months of study commencement.
The level of knowledge regarding operative vaginal birth among obstetric providers, assessed using a validated questionnaire. The knowledge score will be based on correct responses to a series of questions about indications, techniques, benefits, and risks associated with operative vaginal birth.
Within 6 months of study commencement.
Attitudes Toward Operative Vaginal Birth Among Obstetric Providers
Time Frame: Within 6 months of study commencement.
The attitudes of obstetric providers towards operative vaginal birth, measured using a Likert scale in the validated questionnaire. Providers will rate their agreement with statements related to their perceptions and opinions on the use of operative vaginal birth.
Within 6 months of study commencement.
Practices of Operative Vaginal Birth Among Obstetric Providers
Time Frame: Within 6 months of study commencement.
The frequency and context of operative vaginal birth practices among obstetric providers, as reported in the validated questionnaire. This measure will include the number of operative vaginal births performed, preferred techniques, and any barriers to performing these procedures.
Within 6 months of study commencement.
Rate of Cesarean Sections Among Participants
Time Frame: Within 6 months of study commencement.
The percentage of Cesarean sections performed by the obstetric providers participating in the study, as reported in the validated questionnaire. This measure aims to correlate knowledge, attitudes, and practices with the actual rate of Cesarean sections.
Within 6 months of study commencement.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Al-Azhar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 20, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 1, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 27, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 12, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 16, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 3, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 1, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Gyne 2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

As part of this study, Individual Participant Data (IPD) will be shared to facilitate transparency and enable further research in the field of operative vaginal birth practices among obstetricians and gynecologists in Egypt. De-identified IPD will include demographic information, responses from the questionnaire assessing knowledge, attitudes, and practices related to operative vaginal birth, and any additional data pertinent to the study outcomes. Access to the IPD will be granted to researchers with approved proposals demonstrating scientific merit and ethical approval. Data will be made available through a secure, encrypted transfer mechanism, and all users will be required to sign a Data Use Agreement (DUA) outlining terms for responsible data use and confidentiality.

IPD Sharing Time Frame

Data collection for the study will commence on [1, July, 2014] and conclude by [30, October, 2024]. IPD will be accessible for sharing beginning [30, December, 2024] and will remain available for a period of [2 years] following publication of primary study results.

IPD Sharing Access Criteria

Access to IPD will be granted to researchers with scientifically sound proposals aimed at advancing knowledge in the field of operative vaginal birth practices among obstetricians and gynecologists in Egypt. Proposals must include evidence of ethical approval from an institutional review board or equivalent ethics committee. Researchers affiliated with recognized academic, medical, or research institutions will be eligible. Access requests will be evaluated based on the scientific merit of the proposal, feasibility of the research aims, and potential contribution to improving health outcomes. All users must sign a Data Use Agreement (DUA) ensuring confidentiality, ethical data use, and prohibiting attempts to re-identify participants.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings